AIMProteus
AKT Inhibitor Miransertib on Proteus Syndrome - Targeted therapy at NIH
Update: The AIM Proteus Trial is currently is currently on hold.
Approximate patient enrollment date for trial Summer 2021.
Questions about the NIH AIMProteus trial email here or call.
AKT Inhibitor Miransertib on Proteus Syndrome - Targeted therapy at NIH
Update: The AIM Proteus Trial is currently is currently on hold.
Approximate patient enrollment date for trial Summer 2021.
Questions about the NIH AIMProteus trial email here or call.